Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project.
Bernardi E, Camporese G, Bortoluzzi C, Noventa F, Ceccato D, Tonello C, Vohong S, Campello E, Simion C, Imbalzano E, Di Micco P, Callegari E, Simioni P. Bernardi E, et al. Among authors: noventa f. Life (Basel). 2022 Oct 28;12(11):1725. doi: 10.3390/life12111725. Life (Basel). 2022. PMID: 36362880 Free PMC article.
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project.
Bortoluzzi C, Bernardi E, Camporese G, Noventa F, Ceccato D, Tonello C, Vo Hong N, Campello E, Simion C, Imbalzano E, Di Micco P, Callegari E, Simioni P. Bortoluzzi C, et al. Among authors: noventa f. Life (Basel). 2022 Oct 20;12(10):1657. doi: 10.3390/life12101657. Life (Basel). 2022. PMID: 36295091 Free PMC article.
The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.
Pastore G, Bertini M, Bonanno C, Coluccia G, Dell'Era G, De Mattia L, Grieco D, Katsouras G, Maines M, Marcantoni L, Marinaccio L, Paglino G, Palmisano P, Ziacchi M, Zoppo F, Noventa F. Pastore G, et al. Among authors: noventa f. Europace. 2023 May 19;25(5):euad082. doi: 10.1093/europace/euad082. Europace. 2023. PMID: 36974970 Free PMC article. Clinical Trial.
Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study.
Prandoni P, Lensing AWA, Prins MH, Ciammaichella M, Pirillo S, Pace F, Zalunardo B, Bottino F, Ageno W, Muiesan ML, Forlin M, Depietri L, Bova C, Costantini N, Caviglioli C, Migliaccio L, Noventa F, Levi M, Davidson BL, Palareti G; Pulmonary Embolism Dyspnea Italian Study (PEDIS) Investigators. Prandoni P, et al. Among authors: noventa f. J Thromb Haemost. 2023 Jan;21(1):68-75. doi: 10.1016/j.jtha.2022.09.007. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36695397 Free article.
MAC Project-Monitoring Anticoagulant Therapy Observational Study: Rationale and Protocol.
Camporese G, Bernardi E, Bortoluzzi C, Noventa F, Hong NV, Callegari E, Villalta S, Tonello C, Nardin M, Campello E, Spiezia L, Simioni P. Camporese G, et al. Among authors: noventa f. Front Med (Lausanne). 2021 Jan 28;7:584459. doi: 10.3389/fmed.2020.584459. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33585500 Free PMC article.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
Fabbiani M, Lombardi A, Colaneri M, Del Poggio P, Perini P, D'Ambrosio R, Degasperi E, Dibenedetto C, Giorgini A, Pasulo L, Maggiolo F, Castelli F, Brambilla P, Spinelli O, Re T, Lleo A, Rumi M, Uberti-Foppa C, Soria A, Aghemo A, Lampertico P, Baiguera C, Schiavini M, Fagiuoli S, Bruno R; NAVIGATORE-Lombardia Study Group. Fabbiani M, et al. J Viral Hepat. 2021 Mar;28(3):558-568. doi: 10.1111/jvh.13454. Epub 2021 Jan 2. J Viral Hepat. 2021. PMID: 33306247
145 results